CUMBERLAND PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cumberland Pharmaceuticals Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Cumberland Pharmaceuticals Inc Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 14M shares, a 1.46% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 14M -207K -1.46% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 14.1M -248K -1.73% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 14.2M -270K -1.87% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 14.1M -244K -1.7% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 14.2M -219K -1.52% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 14.3M -319K -2.18% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 14.4M -301K -2.04% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 14.4M -376K -2.55% Dec 31, 2022 10-K 2024-03-13
Q3 2022 14.4M -414K -2.79% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 14.6M -276K -1.85% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 14.7M -354K -2.35% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 14.7M -246K -1.64% Dec 31, 2021 10-K 2023-03-13
Q3 2021 14.9M -234K -1.55% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 14.9M -255K -1.68% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 15.1M -234K -1.53% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 15M -275K -1.8% Dec 31, 2020 10-K 2022-03-11
Q3 2020 15.1M -147K -0.97% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 15.2M -290K -1.87% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 15.3M -229K -1.47% Mar 31, 2020 10-Q 2020-05-22
Q4 2019 15.3M -218K -1.41% Dec 31, 2019 10-K 2021-03-12
Q3 2019 15.2M -325K -2.09% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 15.5M -134K -0.86% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 15.5M -180K -1.14% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 15.5M -593K -3.69% Dec 31, 2018 8-K 2020-12-10
Q3 2018 15.6M -226K -1.43% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 15.6M -333K -2.09% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 15.7M -338K -2.1% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 16.1M 0 0% Dec 31, 2017 10-K 2019-03-12
Q3 2017 15.8M -414K -2.56% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 15.9M -299K -1.84% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 16.1M -231K -1.42% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 16.1M -305K -1.86% Dec 31, 2016 10-K 2018-03-09
Q3 2016 16.2M -740K -4.37% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 16.2M -699K -4.13% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 16.3M -639K -3.77% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 16.4M -739K -4.32% Dec 31, 2015 10-K 2017-03-13
Q3 2015 16.9M -488K -2.8% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 16.9M -725K -4.1% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 16.9M -872K -4.89% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 17.1M -867K -4.82% Dec 31, 2014 10-K 2016-03-14
Q3 2014 17.4M -734K -4.04% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 17.7M -646K -3.53% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 17.8M -742K -4% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 18M -952K -5.03% Dec 31, 2013 10-K 2015-03-09
Q3 2013 18.2M -1.02M -5.3% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 18.3M -1.39M -7.07% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 18.5M -1.32M -6.65% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 18.9M -1.08M -5.41% Dec 31, 2012 10-K 2014-03-11
Q3 2012 19.2M -1.04M -5.16% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 19.7M -701K -3.44% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 19.9M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 20M -318K -1.56% Dec 31, 2011 10-Q 2012-11-02
Q3 2011 20.2M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 20.4M Jun 30, 2011 10-Q 2011-08-08
Q4 2010 20.3M Dec 31, 2010 10-K 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.